Annexon, Inc. - common stock (NQ:ANNX)

4.135 -0.055 (-1.31%)

Delayed Quote Updated: 11:04 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Annexon, Inc. - common stock

< Previous 1 2 3 4 5 6 7 8 Next >

7 Top Stocks Under $10: June 2024 Edition ↗

June 24, 2024

While blue-chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification.

Via InvestorPlace

Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting

June 18, 2024

From Annexon Biosciences

Via GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

June 17, 2024

From Annexon Biosciences

Via GlobeNewswire

Annexon Announces Pricing of $125 Million Underwritten Public Offering

June 05, 2024

From Annexon Biosciences

Via GlobeNewswire

ANNX Stock Earnings: Annexon Beats EPS for Q1 2024 ↗

May 13, 2024

ANNX stock results show that Annexon beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ANNX Stock Earnings: Annexon Beats EPS for Q4 2023 ↗

March 26, 2024

ANNX stock results show that Annexon beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 05, 2024

Via Benzinga

Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗

June 05, 2024

Via Benzinga

Annexon Announces Proposed Public Offering of Common Stock

June 04, 2024

From Annexon Biosciences

Via GlobeNewswire

Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings ↗

June 04, 2024

Via Benzinga

Topics Stocks

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 04, 2024

Via Benzinga

Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study ↗

June 04, 2024

Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disability, muscle strength, and ventilation duration.

Via Benzinga

Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results ↗

June 04, 2024

Via Benzinga

Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday ↗

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 04, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 04, 2024

It's time to start Tuesday with a breakdown of the biggest pre-market stock movers traders will want to know about this morning!

Via InvestorPlace

Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome

June 04, 2024

From Annexon Biosciences

Via GlobeNewswire

Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

June 04, 2024

Via Benzinga

Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data

June 03, 2024

Call scheduled for Tuesday, June 4, 2024 at 8:30 a.m. ET

From Annexon Biosciences

Via GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

May 16, 2024

From Annexon Biosciences

Via GlobeNewswire

Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones

May 13, 2024

From Annexon Biosciences

Via GlobeNewswire

Annexon Biosciences to Present at the Bank of America Health Care Conference

May 09, 2024

From Annexon Biosciences

Via GlobeNewswire

Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting

May 07, 2024

From Annexon Biosciences

Via GlobeNewswire

Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

May 01, 2024

From Annexon Biosciences

Via GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

April 16, 2024

From Annexon Biosciences

Via GlobeNewswire

Turnstone Biologics Appoints William Waddill to its Board of Directors

April 16, 2024

From Turnstone Biologics Corp.

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

April 09, 2024

Via Benzinga

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

April 03, 2024

From Annexon Biosciences

Via GlobeNewswire

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday ↗

March 27, 2024

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.